Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods
- PMID: 36203586
- PMCID: PMC9530739
- DOI: 10.3389/fimmu.2022.923387
Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods
Abstract
At the end of 2019, the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, seriously damaged world public health security. Several protein markers associated with virus infection have been extensively explored to combat the ever-increasing challenge posed by SARS-CoV-2. The proteomics of COVID-19 deepened our understanding of viral particles and their mechanisms of host invasion, providing us with information on protein changes in host tissues, cells and body fluids following infection in COVID-19 patients. In this review, we summarize the proteomic studies of SARS-CoV-2 infection and review the current understanding of COVID-19 in terms of the quantitative and qualitative proteomics of viral particles and host entry factors from the perspective of protein pathological changes in the organism following host infection.
Keywords: COVID-19; SARS-CoV-2; protein biomarker; proteomics; virus infection.
Copyright © 2022 Yu, Li, Xin, Sun and Shi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10. J Pathol. 2020. PMID: 32418199 Free PMC article. Review.
-
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.Theranostics. 2020 Jun 12;10(16):7448-7464. doi: 10.7150/thno.48076. eCollection 2020. Theranostics. 2020. PMID: 32642005 Free PMC article. Review.
-
Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing.Mol Cell Proteomics. 2020 Sep;19(9):1503-1522. doi: 10.1074/mcp.RA120.002164. Epub 2020 Jun 26. Mol Cell Proteomics. 2020. PMID: 32591346 Free PMC article.
-
Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):591-597. doi: 10.11817/j.issn.1672-7347.2020.200299. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020. PMID: 32879112 Review. Chinese, English.
-
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20. mBio. 2020. PMID: 32913009 Free PMC article.
Cited by
-
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases.Cell Commun Signal. 2023 May 15;21(1):110. doi: 10.1186/s12964-023-01104-5. Cell Commun Signal. 2023. PMID: 37189112 Free PMC article. Review.
-
Evaluation of serum and urine biomarkers for severe COVID-19.Front Med (Lausanne). 2024 Mar 6;11:1357659. doi: 10.3389/fmed.2024.1357659. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38510452 Free PMC article.
-
Proteomics: Unraveling the Cross Talk Between Innate Immunity and Disease Pathophysiology, Diagnostics, and Treatment Options.Adv Exp Med Biol. 2024;1443:221-242. doi: 10.1007/978-3-031-50624-6_12. Adv Exp Med Biol. 2024. PMID: 38409424 Review.
-
Plasma Proteomics Elucidated a Protein Signature in COVID-19 Patients with Comorbidities and Early-Diagnosis Biomarkers.Biomedicines. 2024 Apr 10;12(4):840. doi: 10.3390/biomedicines12040840. Biomedicines. 2024. PMID: 38672194 Free PMC article.
-
The Impact of Serum/Plasma Proteomics on SARS-CoV-2 Diagnosis and Prognosis.Int J Mol Sci. 2024 Aug 8;25(16):8633. doi: 10.3390/ijms25168633. Int J Mol Sci. 2024. PMID: 39201322 Free PMC article. Review.
References
-
- Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. . Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis (2020) 92:214–7. doi: 10.1016/j.ijid.2020.01.050 - DOI - PMC - PubMed
-
- Park J, Foox J, Hether T, Danko D, Warren S, Kim Y, et al. . Systemic tissue and cellular disruption from SARS-CoV-2 infection revealed in COVID-19 autopsies and spatial omics tissue maps. bioRxiv (2021). Available at: https://www.biorxiv.org
-
- Ravindra NG, Alfajaro MM, Gasque V, Huston NC, Wan H, Szigeti-Buck K, et al. . Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PloS Biol (2021) 19(3):e3001143. doi: 10.1371/journal.pbio.3001143 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous